95741-44-9

Basic information

• Product Name: (4-BROMO-3,5-DIMETHYL)PHENYL BENZYL ETHER
• Synonyms: (4-BROMO-3,5-DIMETHYL)PHENYL BENZYL ETHER;5-(benzyloxy)-2-bromo-1,3-dimethylbenzene
• CAS NO: 95741-44-9
• Molecular Formula: C₁₅H₁₅BrO
• Molecular Weight: 291.18
• Mol File: 95741-44-9.mol
• Article Data: 9

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (4-BROMO-3,5-DIMETHYL)PHENYL BENZYL ETHER(CAS DataBase Reference)
• NIST Chemistry Reference: (4-BROMO-3,5-DIMETHYL)PHENYL BENZYL ETHER(95741-44-9)
• EPA Substance Registry System: (4-BROMO-3,5-DIMETHYL)PHENYL BENZYL ETHER(95741-44-9)

Safety Data

• Hazardous Substances Data: 95741-44-9(Hazardous Substances Data)

Usage

General Description

(4-Bromo-3,5-dimethyl)phenyl benzyl ether is an organic compound with the molecular formula C16H15BrO. It is a member of the benzyl ether family, which are common in organic chemistry and frequently used in organic synthesis. This specific compound contains a bromine atom and two methyl groups on the phenyl ring, providing unique chemical and physical properties. It is commonly used as a reagent in organic reactions and may also have potential applications as a pharmaceutical intermediate or in the development of new materials.

Upstream product

• 7463-51-6 4-bromo-3,5-dimethylphenol 
• 100-39-0 benzyl bromide 
• 100-44-7 benzyl chloride 

Downstream Products

• 75056-97-2 2,6-dimethyl-4-hydroxybenzoic acid 
• 28924-92-7 4-(benzyloxy)-2,6-dimethylbenzaldehyde 
• 865139-24-8 ethyl 6-(acetylamino)-4'-(benzyloxy)-2',6'-dimethylbiphenyl-3-carboxylate 
• 865139-19-1 methyl 4'-(benzyloxy)-2',6,6'-trimethylbiphenyl-3-carboxylate 
• 945669-52-3 (S)-O-benzyl-N-(tert-butoxycarbonyl)-2,6-dimethyltyrosine 
• 123715-02-6 H-Dmt 

Relevant articles and documents

Design, synthesis and evaluation of potent G-protein coupled receptor 40 agonists

GPR40 has emerged as an attractive drug target for the treatment of type 2 diabetes due to its role in the enhancement of insulin secretion with glucose dependency. With the aim to improve the metabolic and safety profiles, a series of novel phenylpropionic acid derivatives were synthesized. Extensive structural optimization led to identification of compounds 22g and 23e as potent GPR40 agonists with moderate liver microsomal stability. All the discovery supported further exploration surrounding this scaffold.

Functionalizing αvβ3- or α5β1-selective integrin antagonists for surface coating: A method to discriminate integrin subtypes in vitro

Stuck with the right choice: αvβ3- or α5β1-selective integrin ligands were functionalized for surface coating without losing activity and selectivity. The coating of nanostructured gold surfaces with these compounds stimulated subtype-selective cell adhesion of genetically modified αvβ3- or α5β1-expressing fibroblasts in vitro. Copyright

AMINOPHENYLPROPANOIC ACID DERIVATIVE

A compound represented by the formula (1): wherein each symbol is as defined in the specification, and a salt thereof and a prodrug thereof unexpectedly have superior GPR40 receptor agonist activity, superior in the properties as a pharmaceutical product such as stability and the like, and can be a safe and useful pharmaceutical agent as a drug for the prophylaxis or treatment of GPR40 receptor related pathology or diseases such as diabetes and the like.